首页> 外文期刊>International Journal of Clinical Pharmacology Research >Life-threatening renal failure caused by vasomotor nephropathy associated with nonsteroidal anti-inflammatory drugs.
【24h】

Life-threatening renal failure caused by vasomotor nephropathy associated with nonsteroidal anti-inflammatory drugs.

机译:由非甾体抗炎药引起的血管舒缩性肾病引起的危及生命的肾衰竭。

获取原文
获取原文并翻译 | 示例
       

摘要

The purpose of this study was to evaluate the prevalence of life-threatening renal failure (RF) caused by vasomotor nephropathy associated with nonsteroidal anti-inflammatory drug (NSAID) treatment (NSAID-RF) and risk factors for this renal impairment in an inception cohort of patients with recently diagnosed uremia treated by emergency hemodialysis in a prospective regional study. There are few published data on this phenomenon. Two hundred fifty-six patients (137 men, 119 women, mean age 68 years [22-95 years]) with acute uremia were treated with emergency hemodialysis in the intensive care unit over a period of 70 months. The patients were from an area of 231,000 inhabitants. Of the 256 patients, clinical data from a group of 79 patients with medical-type renal failure were analyzed in detail. The prevalence of NSAID-RF was 8%. This prevalence decreased to 4% when patients without any other medication affecting compensatory renal hemodynamics were considered. Moreover when nonpharmacological insultswere not taken into account the prevalence decreased to only 1.6%. In 80% of the patients with NSAID-RF, nonpharmacological insults contributed to renal impairment. Both hypotension of cardiac etiology and dehydration/hypovolemia were present in 25% of the patients with this type of RF while urinary tract obstruction was seen in 1%. In 75% patients with NSAID-RF the underlying nephropathies were identified. NSAID-RF was not frequent. The population at greatest risk for renal functional alteration associated with NSAID therapy included patients with dehydration/hypovolemia, hypotension of cardiac etiology and those with pre-existing renal impairment, especially with vascular and analgesic nephropathy.
机译:这项研究的目的是评估与非甾体抗炎药(NSAID)治疗相关的血管舒缩性肾病引起的危及生命的肾衰竭(RF)的患病率,以及该人群在始发队列中发生此肾功能损害的危险因素在一项前瞻性区域研究中,对通过紧急血液透析治疗的最近诊断为尿毒症的患者进行了分析。关于这种现象的公开数据很少。在重症监护病房中,对急性尿毒症的256例患者(男性137例,女性119例,平均年龄68岁[22-95岁])进行了紧急血液透析治疗,时间为70个月。这些患者来自231,000名居民。在这256例患者中,详细分析了79例医学型肾衰竭患者的临床资料。 NSAID-RF的患病率为8%。当考虑没有其他药物影响代偿性肾脏血液动力学的患者时,该患病率降至4%。此外,如果不考虑非药物损伤,患病率仅下降至1.6%。在80%的NSAID-RF患者中,非药物损伤导致了肾功能损害。 25%的这类RF患者同时存在心脏病因低血压和脱水/血容量减少,而1%的患者出现尿路阻塞。在75%的NSAID-RF患者中,发现了潜在的肾病。 NSAID-RF并不常见。与NSAID治疗相关的肾功能改变风险最高的人群包括脱水/血容量不足,心脏病因低血压和先前存在肾功能不全,尤其是血管性和镇痛性肾病的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号